Ticker | ROP (Nasdaq) |
Earnings Date | July 23, 2026 (pre-market); call 8:00 AM ET |
Reporting Period | Q2 2026 (quarter ended June 30, 2026) |
Prepared | July 22, 2026 |
Last Earnings | April 23, 2026 (Q1 2026) |
Sector ETF Benchmark | IGV (iShares Expanded Tech-Software ETF) |
Key Takeaway: The setup is modestly constructive — consensus sits at the low end of management's Q2 guidance range, the stock has given back all of its post-Q1 gains, and the bar is achievable, but the single biggest swing factor is whether organic growth can hold at 5–6% against a tougher TEP comp and continued GovCon softness.
Heading into Q2 2026, the bar for Roper is manageable: consensus adjusted DEPS of ~$5.28 sits at the low end of management's guided range of $5.25–$5.30, implying the Street is not pricing in upside. Management's posture on the Q1 call was constructive but deliberately conservative — they raised full-year DEPS guidance by $0.50 at the midpoint to $21.80–$22.05 while explicitly refusing to bake in any recovery in Deltek GovCon, DAT freight, or Neptune, leaving meaningful optionality if any of those segments inflect. Estimate revisions have been broadly stable since the Q1 print, with the 2026FY consensus holding near $21.94, suggesting the Street has largely digested the raise without adding incremental optimism. The stock has underperformed IGV materially since last earnings — down ~7% vs. IGV up ~7% — reflecting both sector rotation away from lower-growth compounders and specific concerns about TEP margin pressure from bronze ingot inflation at Neptune and a tough Q2 comp. The wildcard is software bookings: if enterprise software bookings (core up low-double digits TTM through Q1) sustain momentum and AI-influenced wins at CentralReach, Vertafore, and ConstructConnect continue to broaden, the market may begin to re-rate the organic growth trajectory higher — the one catalyst that could close the valuation gap to historical levels.
Key Takeaway: Consensus is a low bar — DEPS sits at the midpoint of guidance and organic growth expectations (~4.3%) are below the 5–6% full-year guide. The bigger swing factor is organic growth: a 5%+ print would signal Q1 was not a one-quarter fluke and could re-rate the stock.
KPI | Q1 2026 Actual | Q2 2025 Actual (Prior Year) | Q2 2026 Consensus Estimate | YoY Change | Q2 2026 Guidance | Consensus vs. Guidance Midpoint |
Revenue (Net Sales) | $2,095M | $1,944M | $2,097M | +7.9% YoY | ~8% total growth (FY guide) | In line |
Adjusted DEPS (Operating EPS) | $5.16 | $4.87 | $5.28 | +8.4% YoY | $5.25–$5.30 | −0.2% (at low end) |
Organic Revenue Growth | 6% | 7% | ~4.3% | −2.7pp YoY | 5–6% (FY guide) | Below FY midpoint |
EBITA Margin (Operating) | 37.6% | 39.4% | ~38.5% | −0.9pp YoY | N/A (not guided explicitly) | N/A |
Adjusted Free Cash Flow | $562M | $403M | $540M | +34% YoY | N/A (not guided quarterly) | N/A |
Sources: Visible Alpha Consensus and Actuals Data; Q1 2026 Earnings Release (April 23, 2026); Q1 2026 Earnings Call Transcript. Q2 2026 consensus estimates as of July 22, 2026. Q1 2026 Actual DEPS of $5.16 per earnings release; Q2 2025 Actual DEPS of $4.87 per earnings release. Organic growth consensus ~4.3% and EBITA margin ~38.5% from Visible Alpha. Adjusted FCF Q2 2025 actual $403M and Q2 2026 consensus ~$540M from Visible Alpha.
Quarter | KPI | Reported | Consensus | Surprise % | Result |
Q1 2026 | Adj. DEPS | $5.16 | $4.99 | +3.4% | Beat |
Q1 2026 | Organic Growth | 6% | ~4.6% | +1.4pp | Beat |
Q4 2025 | Adj. DEPS | $5.21 | $5.14 | +1.4% | Beat |
Q4 2025 | Organic Growth | 4% | ~5.3% | −1.3pp | Miss |
Q3 2025 | Adj. DEPS | $5.14 | $5.11 | +0.6% | Beat |
Q3 2025 | Organic Growth | 6% | ~7.7% | −1.7pp | Miss |
Q2 2025 | Adj. DEPS | $4.87 | $4.82 | +1.0% | Beat |
Q2 2025 | Organic Growth | 7% | ~6.3% | +0.7pp | Beat |
Q1 2025 | Adj. DEPS | $4.78 | $4.74 | +0.8% | Beat |
Q1 2025 | Organic Growth | 5% | ~5.0% | In line | In Line |
Q4 2024 | Adj. DEPS | $4.81 | $4.76 | +1.1% | Beat |
Q4 2024 | Organic Growth | 7% | ~5.7% | +1.3pp | Beat |
Q3 2024 | Adj. DEPS | $4.62 | $4.52 | +2.1% | Beat |
Q3 2024 | Organic Growth | 4% | ~4.7% | −0.7pp | Miss |
Q2 2024 | Adj. DEPS | $4.48 | $4.47 | +0.1% | Beat |
Q2 2024 | Organic Growth | 4% | ~5.0% | −1.0pp | Miss |
Pattern: ROP has beaten adjusted DEPS consensus in all 8 of the last 8 quarters; organic growth has been more volatile, missing in 4 of 8 quarters — the key risk is that the Street's ~4.3% Q2 organic estimate may still be too high given the TEP segment comp headwind and continued GovCon softness flagged on the Q1 call.
Sources: Visible Alpha Consensus and Actuals Data; ROP Q1 2026 Earnings Release; ROP Q1 2026 Earnings Call Transcript.
Key Takeaway: Guidance has not been revised since the Q1 print — the $5.25–$5.30 Q2 DEPS range and $21.80–$22.05 full-year range stand as issued April 23. Tone is constructive but deliberately conservative, with management explicitly not baking in any recovery in three challenged segments.
Metric | Initial Guidance (Q1 2026 Call, Apr 23) | Revised Guidance | Current Consensus | Note |
Q2 2026 Adjusted DEPS | $5.25–$5.30 | — | $5.28 | No post-earnings revision; consensus at low end of range |
FY 2026 Adjusted DEPS | $21.80–$22.05 (raised from $21.30–$21.55) | — | $21.94 | Raised $0.50 at midpoint on Q1 beat + buyback benefit; no further revision since |
FY 2026 Total Revenue Growth | ~8% | — | ~8% (in line) | Maintained; consensus tracking guidance |
FY 2026 Organic Revenue Growth | 5–6% | — | ~5.6% | Consensus near midpoint; no GovCon, DAT, or Neptune recovery assumed |
FY 2026 Tax Rate | ~21% (Q2 slightly below) | — | ~21% | Unchanged; Q2 expected slightly below 21% |
Deltek GovCon | No inflection assumed; recurring revenue mid-single-digit+ | — | N/A (not separately guided) | Mgmt explicitly not baking in GovCon or OBBB benefit; will adjust as conditions warrant |
Neptune / TEP Segment | No Neptune recovery; raw material pressure continues in Q2, improving H2 | — | N/A (not separately guided) | Bronze ingot inflation headwind; surcharge approach abandoned; regular-way pricing recovery over coming quarters |
Share Repurchases | $3.8B remaining authorization; guidance excludes future buybacks | — | N/A | 6M shares repurchased since Nov 2025 (~6% of SO); $5B+ total deployment capacity |
Source: ROP Q1 2026 Earnings Call Transcript (April 23, 2026); ROP Q1 2026 Earnings Release (April 23, 2026); Visible Alpha Consensus and Actuals Data.
Key Takeaway: Estimates have been broadly stable-to-slightly-lower since the Q1 print — the FY 2026 DEPS consensus of $21.94 is essentially flat vs. the $21.93 level immediately post-Q1, suggesting the Street has absorbed the guidance raise without adding incremental optimism. The gap between consensus and the guidance midpoint is narrow, leaving little cushion if Q2 disappoints.
KPI (Period) | Estimate ~5 Days Post Q1 Earnings (Apr 30, 2026) | Current Consensus (Jul 22, 2026) | Estimate Δ (%) | Initial Guidance (Q1 Call) | Current Guidance | Guidance Δ | Consensus vs. Guidance Midpoint |
Adj. DEPS — Q2 2026 | $5.31 | $5.28 | −0.6% | $5.25–$5.30 | Unchanged | — | −0.2% (at low end) |
Adj. DEPS — FY 2026 | $21.93 | $21.94 | +0.1% | $21.80–$22.05 | Unchanged | — | −0.1% (at midpoint) |
Revenue — Q2 2026 | $2,097M | $2,097M | Flat | ~8% total growth (FY) | Unchanged | — | In line |
Revenue — FY 2026 | $8,547M | $8,547M | Flat | ~8% total growth | Unchanged | — | In line |
Organic Growth — Q2 2026 | ~4.3% | ~4.3% | Flat | 5–6% (FY) | Unchanged | — | Below FY midpoint; Q2 comp tougher |
Adj. DEPS — FY 2027 | $23.83 | $23.98 | +0.6% | N/A (not guided) | N/A | — | N/A |
The estimate revision picture is remarkably stable — virtually no movement in DEPS or revenue consensus since the Q1 print. The slight drift lower in Q2 DEPS ($5.31 → $5.28) likely reflects the Street trimming for the tougher TEP comp and continued GovCon softness rather than any fundamental deterioration. FY 2027 estimates have nudged slightly higher (+0.6%), suggesting analysts are incrementally more constructive on the out-year compounding story.
Source: Visible Alpha Consensus and Actuals Data (as-of April 30, 2026 and July 22, 2026); ROP Q1 2026 Earnings Call Transcript.
Key Takeaway: ROP has been a significant underperformer since Q1 earnings — down ~7.4% vs. IGV +6.5% and S&P 500 +5.5% — driven by multiple compression rather than estimate cuts, as consensus has barely moved. The stock is essentially flat to its Q1 earnings-day close, suggesting the market is in a show-me mode ahead of Q2.
Series | Apr 23, 2026 (Base) | Jul 22, 2026 | Return Since Last Earnings | Peak (Indexed) | Trough (Indexed) |
ROP | $363.76 | $336.71 | −7.4% | ~$364 (Jul 6) | ~$316 (May 13) |
IGV (Software ETF) | $83.57 | $89.02 | +6.5% | ~$107 (May 29) | ~$84 (Apr 30) |
S&P 500 (SPY) | $708.45 | $747.41 | +5.5% | ~$757 (May 29) | ~$708 (Apr 23) |
Performance Narrative: ROP sold off sharply in mid-May (trough ~$316, −13% from earnings) as the broader market rallied on tariff relief and AI enthusiasm — a period where ROP's lower-growth, non-AI-pure-play profile was a headwind. The stock partially recovered in late June/early July on renewed M&A speculation and buyback support, briefly touching $364 on July 6 before pulling back again to $337 by July 22. The ~14pp underperformance vs. IGV since earnings is almost entirely multiple compression — consensus estimates are flat — reflecting the market's skepticism about whether ROP's organic growth re-acceleration is durable. The stock enters Q2 earnings at essentially the same price as Q1 earnings day, creating a clean setup: a beat-and-raise could catalyze a meaningful re-rating, while a miss on organic growth would likely retest the May lows.
Source: Stock Price Data (Yahoo Finance). ROP, IGV, SPY closing prices April 23 – July 22, 2026.
Key Takeaway: The most material development is the $3B additional buyback authorization (bringing remaining capacity to $3.8B), which provides a meaningful EPS tailwind and signals management conviction in the valuation dislocation. No M&A has been announced, consistent with management's commentary that private seller processes have paused amid public market volatility.
Key Takeaway: No open-market insider purchases or discretionary sales were identified via Form 4 filings in the period since Q1 earnings (April 23 – July 22, 2026). The absence of insider buying is not alarming given the company's aggressive corporate buyback program ($3.8B remaining authorization), which effectively substitutes for individual insider signaling. No unusual activity to flag.
Name | Title | Transaction Type | Value | Date | Note |
N/A | N/A | N/A | N/A | N/A | No open-market buys or discretionary sales identified in the post-Q1 window (Apr 23 – Jul 22, 2026) |
Source: SEC Form 4 filings database query for ROP, April 23 – July 22, 2026. No open-market purchase (code P) or sale (code S) transactions returned.
Key Takeaway: Three peers reported in the last 60 days with commentary directly relevant to ROP’s Q2 2026 reporting period: VEEV (vertical software demand / AI monetization), SAIC (GovCon end-market), and JBHT (freight market / DAT read-through). The aggregate signal is mixed-to-constructive: vertical software demand is healthy, GovCon is stabilizing but not yet inflecting, and the freight market is tightening meaningfully — a potential positive for DAT that management has not yet baked into guidance.
Methodology Note: Only commentary from the last 60 days (May 22 – July 22, 2026) that speaks to the current reporting period (calendar Q2 2026, April–June 2026) or forward outlook is included below. Prior-quarter result commentary from these peers has been excluded. Each read-through is labeled with its relevance to specific ROP segments and caveated where the linkage is indirect.
ROP Relevance: Vertical software demand signal; AI monetization framework read-through for ROP’s Application Software segment (Vertafore, CentralReach, ConstructConnect, iPipeline). VEEV’s fiscal Q1 2027 ended April 30, 2026, overlapping with the first month of ROP’s Q2 2026.
Caveat: VEEV serves life sciences exclusively; ROP’s software businesses serve insurance, construction, legal, ABA therapy, and other verticals. The read-through is thematic (vertical software demand, AI adoption pace, monetization model) rather than direct end-market overlap.
ROP Relevance: Direct GovCon end-market read-through for Deltek, ROP’s largest Application Software business. SAIC’s fiscal Q1 2027 ended May 1, 2026, covering the first two months of ROP’s Q2 2026. Deltek sells ERP and project management software to government contractors — SAIC is a direct Deltek customer archetype.
Caveat: SAIC is a government contractor (services), not a software company. The read-through is to Deltek’s end-market demand (GovCon enterprise software procurement decisions), not to ROP’s own revenue model. SAIC’s own revenue headwinds (RITS recompete) are company-specific and do not directly translate to Deltek demand.
ROP Relevance: Most direct and timely read-through for DAT Freight & Analytics (part of ROP’s Network Software segment). JBHT reported Q2 2026 results (April–June 2026) — the exact same period as ROP’s Q2 2026. DAT operates the largest freight marketplace in North America; JBHT is one of its largest users and a direct proxy for freight market conditions.
Caveat: DAT’s revenue model is subscription/ARPU-based, not volume-based — a tightening freight market improves DAT’s carrier-side ecosystem growth and ARPU expansion but does not directly translate to a proportional revenue uplift. Management has explicitly not baked in a freight recovery in guidance.
Sources: VEEV FQ1 2027 Earnings Call Transcript (June 3, 2026); SAIC FQ1 2027 Earnings Call Transcript (June 1, 2026); JBHT Q2 2026 Earnings Call Transcript (July 15, 2026).